TNFSF10 and neoplasm: In line with our results from Fig. 7a–c, H & E  staining revealed that H5CmTERT-Ad/TRAIL-treated mice had lower tumour burden and markedly higher accumulation of oncolytic adenovirus than H5CmTERT-Ad-treated mice (Fig. 8c).